By downregulating DUXAP8 in lung cancer cells, it is not only possible to inhibit the proliferation of pancreatic cancer cells through silencing CDKN1A and KLF2, but also to induce their apoptosis [18]. This evidence concerns the gene CDKN1A and lung cancer.